KEY FINDINGS
The Germany sleep apnea therapeutics and diagnostics market is set to register a CAGR of 6.47% during the forecast period, 2021-2026. The market growth is primarily driven by the presence of several respiratory care medical device companies and the high healthcare expenditure.
MARKET INSIGHTS
If left untreated, sleep-wake disorders like obstructive sleep apnea and insomnia can lead to severe health problems. One of the most common devices for sleep apnea treatment is continuous positive airway pressure. Germany is home to prominent sleep apnea devices companies like Itamar Medical Ltd, ResMed Inc, Medtronic PLC, Koninklijke Philips NV, etc. Also, the country is witnessing growing side-effects of urban lifestyle like diabetes, anxiety, technological advancements, and obesity, and a high prevalence of obstructive sleep apnea.
Due to the pandemic, the clinical testing of sleep apnea has been suspended. As per the European Respiratory Journal study on sleep apnea management during the pandemic in 2020, the clinical PSG testing number decreased to 20% from 92.5% across the sleep centers in Europe, including German Sleep Society Center. Moreover, teleconsultation has dipped from 30% to 27.5%. Such aspects constitute the German sleep apnea market.
COMPETITIVE INSIGHTS
Some of the eminent companies in the market are GE Healthcare, Somnomedics GmbH, Invacare Corporation, Koninklijke Philips NV, Medtronic Plc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
'
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. KEY GROWTH ENABLERS
2.5. KEY CHALLENGES
3. KEY ANALYTICS
3.1. IMPACT OF COVID-19 ON SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
3.2. KEY MARKET TRENDS
3.3. PORTER'S FIVE FORCES ANALYSIS
3.3.1. BUYERS POWER
3.3.2. SUPPLIERS POWER
3.3.3. SUBSTITUTION
3.3.4. NEW ENTRANTS
3.3.5. INDUSTRY RIVALRY
3.4. REGULATORY FRAMEWORK
3.5. SUPPLY CHAIN ANALYSIS
3.6. OPPORTUNITY MATRIX
3.7. VENDOR LANDSCAPE
4. MARKET BY PRODUCT TYPE
4.1. THERAPEUTICS
4.1.1. POSITIVE AIRWAY PRESSURE (PAP) DEVICES
4.1.2. OXYGEN DEVICES
4.1.3. MASKS AND ACCESSORIES
4.1.4. ORAL APPLIANCES
4.1.5. ADAPTIVE SERVO VENTILATION (ASV) DEVICES
4.2. DIAGNOSTICS AND MONITORING
4.2.1. POLYSOMNOGRAPHY DEVICE (PSG)
4.2.2. OXIMETER
4.2.3. ACTIGRAPHY MONITORING DEVICE
4.2.4. RESPIRATORY POLYGRAPH
4.2.5. SLEEP APNEA SCREENING DEVICE
4.2.6. OTHER DIAGNOSTICS AND MONITORING DEVICES
5. MARKET BY END-USER
5.1. HOSPITALS & SLEEP LABORATORIES
5.2. HOME CARE SETTINGS
6. COMPETITIVE LANDSCAPE
6.1. KEY STRATEGIC DEVELOPMENTS
6.1.1. MERGERS & ACQUISITIONS
6.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
6.1.3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
6.1.4. BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS
6.2. COMPANY PROFILES
6.2.1. GE HEALTHCARE
6.2.2. INVACARE CORPORATION
6.2.3. MEDTRONIC PLC
6.2.4. KONINKLIJKE PHILIPS NV
6.2.5. SOMNOMEDICS GMBH
1. GE HEALTHCARE
2. INVACARE CORPORATION
3. MEDTRONIC PLC
4. KONINKLIJKE PHILIPS NV
5. SOMNOMEDICS GMBH
